LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]

Code Context



        trigger_error($message, E_USER_DEPRECATED);

    }

$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]

deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]

Code Context



        trigger_error($message, E_USER_DEPRECATED);

    }

$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]

deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]

Code Context

            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {

$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-trace').style.display = (document.getElementById('cakeErr68009622ad418-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68009622ad418-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-code').style.display = (document.getElementById('cakeErr68009622ad418-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-context').style.display = (document.getElementById('cakeErr68009622ad418-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68009622ad418-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68009622ad418-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25386,
		&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673420,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25386,
	&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673420,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25386
$metaTitle = &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;
$metaDesc = &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle | Im4change.org</title>
    <meta name="description" content="
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prevalence of TB reduces, says WHO -Manjiri Damle</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>PUNE: </em>As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.</p><p align="justify">According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.</p><p align="justify">With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.</p><p align="justify">The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.</p><p align="justify">The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'

Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]

Code Context

            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));

$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-trace').style.display = (document.getElementById('cakeErr68009622ad418-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68009622ad418-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-code').style.display = (document.getElementById('cakeErr68009622ad418-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-context').style.display = (document.getElementById('cakeErr68009622ad418-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68009622ad418-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68009622ad418-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25386,
		&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673420,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25386,
	&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673420,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25386
$metaTitle = &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;
$metaDesc = &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle | Im4change.org</title>
    <meta name="description" content="
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prevalence of TB reduces, says WHO -Manjiri Damle</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>PUNE: </em>As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.</p><p align="justify">According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.</p><p align="justify">With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.</p><p align="justify">The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.</p><p align="justify">The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'

header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Code Context

                    $value

                ), $first);

                $first = false;

$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-trace').style.display = (document.getElementById('cakeErr68009622ad418-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr68009622ad418-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-code').style.display = (document.getElementById('cakeErr68009622ad418-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr68009622ad418-context').style.display = (document.getElementById('cakeErr68009622ad418-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr68009622ad418-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr68009622ad418-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 25386,
		&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4673420,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 25386,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 25386,
	&#039;title&#039; =&gt; &#039;Prevalence of TB reduces, says WHO -Manjiri Damle&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;prevalence-of-tb-reduces-says-who-manjiri-damle-4673420&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4673420,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 25386
$metaTitle = &#039;LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle&#039;
$metaKeywords = &#039;Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health&#039;
$metaDesc = &#039;
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;&lt;em&gt;PUNE: &lt;/em&gt;As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/prevalence-of-tb-reduces-says-who-manjiri-damle-4673420.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle | Im4change.org</title>
    <meta name="description" content="
-The Times of India



PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Prevalence of TB reduces, says WHO -Manjiri Damle</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify"><br /><em>PUNE: </em>As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.</p><p align="justify">According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.</p><p align="justify">With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.</p><p align="justify">The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.</p><p align="justify">The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'

header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head> <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 25386, 'title' => 'Prevalence of TB reduces, says WHO -Manjiri Damle', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012. According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013. With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001. The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes. The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. ', 'credit_writer' => 'The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'prevalence-of-tb-reduces-says-who-manjiri-damle-4673420', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4673420, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 25386, 'metaTitle' => 'LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle', 'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health', 'metaDesc' => ' -The Times of India PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...', 'disp' => '<div align="justify">-The Times of India</div> PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. ', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 25386, 'title' => 'Prevalence of TB reduces, says WHO -Manjiri Damle', 'subheading' => '', 'description' => '<div align="justify"> -The Times of India </div> PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012. According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013. With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001. The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes. The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. ', 'credit_writer' => 'The Times of India, 12 July, 2014, http://timesofindia.indiatimes.com/Home/Science/Prevalence-of-TB-reduces-says-WHO/articleshow/38272648.cms', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'prevalence-of-tb-reduces-says-who-manjiri-damle-4673420', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4673420, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {}, (int) 4 => object(Cake\ORM\Entity) {}, (int) 5 => object(Cake\ORM\Entity) {}, (int) 6 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 25386 $metaTitle = 'LATEST NEWS UPDATES | Prevalence of TB reduces, says WHO -Manjiri Damle' $metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),MDR-TB,Tuberculosis,Health,World Health Organization,WHO,Public Health' $metaDesc = ' -The Times of India PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the...' $disp = '<div align="justify">-The Times of India</div> PUNE: As per WHO estimations, prevalence of Tuberculosis per lakh population in India has reduced from 465 in the year 1990 to 230 in year 2012. Tuberculosis mortality per lakh population has reduced from 38 in the year 1990 to 22 in year 2012.According to the WHO report released recently the estimated proportion of Multi-Drug Resistant TB cases is not increasing. It is less than 3 percent among new TB cases and between 12-17 percent among re-treatment TB cases. However, the detection of MDR-TB cases has been increasing due to availability of more diagnostic facilities for MDR TB and coverage of the entire country by management of Drug Resistant TB in the Revised National TB Control Programme (RNTCP), between 2007 and 2013.With effective anti-TB Drug regimens administered under the globally acclaimed DOTS strategy, RNTCP has been consistently achieving more than 85 percent treatment success rates among New Smear Positive Patients since the year 2001.The anti-TB drug regimens used for treatment of MDR-TB under the Revised National Tuberculosis Control Programme are formulated by National experts in accordance with WHO Guidelines. The treatment outcomes among MDR-TB patients are comparable with Global outcomes.The first-line drugs used for new TB cases under RNTCP are a combination of Rifampicin, Isoniazid, Ethambutol and Pyrazinamide, administered as standardized treatment regimen. Injection Streptomycin is an additional drug given to re-treatment cases. ' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51